cnbc semaglutide New GLP-1 news: reports a tiny implant is the latest bet to help patients maintain weight loss. Important context: this is early-stage research and business news, not a currently approved The Food and Drug Administration

For that reason, many of these medications are FDA-approved and indicated for diabetes treatment

Chang Yang, Si

However, studies have also found that GLP-1 therapies can result in the loss of muscle mass

A qualified medical provider can help: Evaluate candidacy Review medical history Assess safety concerns Recommend evidence-based protocols Monitor results and side effects At Weston Medical Health & Wellness, patient education and individualized care remain essential components of wellness planning

During this time, the fluctuations in estrogen and progesterone levels are most pronounced, leading to frequent and intense hot flashes

doi: 10.1016/j.fitote.2024.106372 24 ZhouWWangJDingLCaiRChengJLiangPet al